Sarepta Therapeutics, Inc. - Performance Stock Units Award

On August 5, 2025, Louise Rodino-Klapac, President of R&D and Tech Ops at Sarepta Therapeutics, Inc., was awarded 6,250 Performance Stock Units (PSUs). These PSUs were granted on March 1, 2024, and the number of shares earned is based on the Compensation Committee's determination of the company's achievement of prescribed milestones. The earned PSUs will vest on March 1, 2026, provided that Rodino-Klapac continues to provide service to the company through the vesting date. The transaction was reported under Form 4, indicating a change in beneficial ownership. The PSUs are directly owned by Rodino-Klapac and are convertible into common stock.